跳到主要內容區塊
內分泌新陳代謝科 Division Of Endocrinology & Metabolism
:::快捷選單
icon網路掛號 icon看診進度 icon即時動態 衛教專區 icon服務諮詢 icon交通指南 icon健康檢查 icon常見問答 該看哪一科
:::內分泌新陳代謝科 > 公開資訊 > 著作研究

著作研究

引用 (7)
更新日期 2018/10/17 17:13:15
點閱 683

105年

  1.  The Impact of Creatinine Clearance Rate, Daily Urinary Albumin, and Their Joint Effect on Predicting Death in Diabetic Inpatients
    After Discharge: An Observational Study.Medicine (Baltimore). 2016 Feb;95(6):e2804
  2. Glycemic excursions are positively associated with changes in duration of asymptomatic hypoglycemia after treatment intensification
    in patients with type 2 diabetes.Diabetes Res Clin Pract. 2016 Jan
  3.  Association of MMP-9 to TIMP-1 ratio with long-term body weight and waist circumference after dietary weight reduction in men with
    metabolic syndrome.Clin Chim Acta. 2016 Jan 15;452:182-4.
  4. Epigenetic regulation of HGK/MAP4K4 in T cells of type 2 diabetes patients.Oncotarget. 2016 Feb 24
  5. Relationship between percentage of mean arterial pressure at the ankle and mortality in subjects with normal ankle-brachial index: An
    observational study.BMJ Open (accepted)
  6. Genetics of Coronary Artery Disease in Taiwan: A Cardiometabochip Study by the Taichi Consortium.PLoS One 11卷, 3冊, e0138014;
    1-13頁, 2016年
  7. Skeletal muscle proteolysis is associated with sympathetic activation and TNF--ubiquitin-proteasome pathway in liver cirrhotic rats.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
  8. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.SCIENCE
  9. Genetic Variation in the Human SORBS1 Gene is Associated With Blood Pressure Regulation and Age at Onset of Hypertension:A 
    SAPPHIRe Cohort Study.MEDICINE
  10. Efficacy and tolerability of exenatide twice daily and exenatide once weekly in Asian versus White patients with type 2 diabetes 
    mellitus: A pooled analysis.DIABETES RESEARCH AND CLINICAL PRACTICE
  11.  Acarbose reduces body weight irrespective of glycemic control in patients with diabetes: results of a worldwide,  non-interventional, observational study data pool.JOURNAL OF DIABETES AND ITS COMPLICATIONS
  12. Statin treatment is associated with a negative correlation between NT-proBNP and insulin resistance in patients without history of heart 
    failure.CLINICA CHIMICA ACTA
  13. The development of a questionnaire measure of diabetes-related distress in Chinese-speaking patients: the Diabetes-Related Distress 
    Questionnaire (DRDQ) 25卷3冊 721-729頁QUALITY OF LIFE RESEARCH
  14. Modulation of microRNA Expression in Subjects with Metabolic Syndrome and Decrease of Cholesterol Efflux from Macrophages via 
    microRNA-33-Mediated Attenuation of ATP-Binding Cassette Transporter A1 Expression by Statins 11卷5冊 e0154672.PLoS One
  15. Simplifying the audit of risk factor recording and control: A report from an international study in 11 countries.European Journal of 
    Preventive Cardiology
  16. Relationship between body weight and the increment in serum brain-derived neurotrophic factor after oral glucose challenge in men
    with obesity and metabolic syndrome, 期刊:MEDICINE, 65卷, 43冊, e5260頁, 2016年, MEDICINE  

研究計劃

  1. 許惠恒:二甲雙胍調控巨噬細胞抗發炎與細胞極化之機轉探討(院內計畫)
  2. 許惠恒:糖尿病和結腸直腸癌:從基礎到臨床醫學研究(院內計畫)
  3. 許惠恒:運用基因體學鑑定糖尿病與結腸直腸癌交互作用之基因調控(院內計畫)
  4. 許惠恒:芳香烴受體調控NADPH氧化酶-4及氧化壓力在糖尿病腎病變機轉之探討(院內計畫)
  5. 李奕德:腦源性神經滋養因子與血管新生因子在骨骼肌的關係與影響(科技部計畫)
  6. 李奕德:誘導性多功能幹細胞於第二型糖尿病視網膜病變之機轉探討與治療策略應用(三年期)(榮台聯大計畫)
  7. 李奕德:纖維母細胞生長因子19對高血糖造成內皮前驅細胞傷害的影響(國衛院計畫)
  8. 李奕德:纖維母細胞生長因子21對高血糖造成內皮前驅細胞傷害的影響(陽明大學計畫)
  9. 李奕德:住院接受心導管檢查的非糖尿病患者之未診斷血糖異常,血糖變異度,及內皮前驅細胞之研究(院內計畫)

104年

  1. Glycemic variability and diabetes retinopathy: A missing link.JOURNAL OF DIABETES AND ITS COMPLICATIONS29卷,2冊,
    302-306頁,104年
  2. Linagliptin improves glycemic control after 1 year as add-on therapy to basal insulin in Asian patients with type 2 diabetes mellitus. CURRENT MEDICAL RESEARCH AND OPINION 31卷,3冊,503-512頁,104年
  3. New genetic loci link adipose and insulin biology to body fat distribution.NATURE 518卷,7538冊,187-196頁,104年
  4. Weight loss reduces serum monocyte chemoattractant protein-1 concentrations in association with improvements in renal injury in obese men with metabolic syndrome. CLINICAL CHEMISTRY AND LABORATORY MEDICINE 53卷,4冊,6235-629頁,104年
  5. Brain-derived neurotrophic factor correlated with muscle strength in subjects undergoing stationary bicycle exercise training. JOURNAL OF DIABETES AND ITS COMPLICATIONS 29卷,3冊,367-371頁,104年
  6. Genetic studies of body mass index yield new insights for obesity biology.NATURE 518卷,冊,197-206頁,2015年
  7. Assessment of Glomerular Filtration Rate Based on Alterations of Serum Brain-Derived Neurotrophic Factor in Type 2 Diabetic Subjects Treated with Amlodipine/Benazepril or Valsartan/Hydrochlorothiazide.DISEASE MARKERS 2015卷,780743冊,1-8頁,
    2015年電子期刊
  8. Differential regulation of protein expression in response to polyunsaturated fatty acids in the liver of apoE-knockout mice and 
    in HepG2 cells. JOURNAL OF BIOMEDICAL SCIENCE 22卷,12冊,1-14頁,104年
  9.  Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient.JOURNAL OF GLAUCOMA 24卷,4冊,e31-e33頁,104年
  10.  Association of Short-Term Use of Nonsteroidal Anti-Inflammatory Drugs With Stroke in Patients With Hypertension. STROKE 46卷4冊,
    996-1003頁,104年
  11.  Low-frequency and rare exome chip variants associate with fasting glucose and type 2 diabetes susceptibility. Nature Communications
    6卷5897冊,1-16頁,104年
  12. Impact of treatment with saxagliptin on glycaemic stability and β-cell function in the SAVOR-TIMI 53 study. DIABETES OBESITY &
    METABOLISM 17卷5冊,487-494頁104年
  13. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.NEW ENGLAND JOURNAL OF MEDICINE373卷3冊,232-242頁,104
  14. The Effect of Diabetes, Hyperlipidemia, and Statins on the Development of Rotator Cuff Disease  A Nationwide, 11-Year,
    Longitudinal,Population-Based Follow-up Study.AMERICAN JOURNAL OF SPORTS MEDICINE 43卷,9冊,2126-2132頁,104年
  15. Comparing HbA1c, fasting and 2-h plasma glucose for screening for abnormal glucose regulation in patients undergoing 
    coronary angiography. CLINICAL CHEMISTRY AND LABORATORY MEDICINE 53卷,9冊,1441-1449頁,104年
  16. A new formula for estimation of low-density lipoprotein cholesterol in an ethnic Chinese population.CLINICAL CHEMISTRY AND 
    LABORATORY MEDICINE53卷,11冊,1871-1879頁,104年
  17. ciculating adipokines and insulin resistance in subjects with combined cardiac and metabolic syndrome X. Diabetology & Metabolic 
    Syndrome 7卷,83冊,1-8頁,104年
  18. Use of an α-Glucosidase Inhibitor and the Risk of Colorectal Cancer in Patients With Diabetes: A Nationwide, Population-Based 
    Cohort Study. DIABETES CARE 38卷,11冊,2068-2074頁,104年
  19. Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 Diabetes. DIABETES CARE 38卷,11冊,2106-2114頁,104年
  20. Value of Chromosome 9p21 Polymorphism for Prediction of Cardiovascular Mortality in Han Chinese Without Coronary Lesions: 
    An Observational Study. MEDICINE 94卷,39冊,e1538;1-6頁,104年
  21. Factors associated with fibroblast growth factor 19 increment after oral glucose loading in patients who were previously admitted 
    for coronary angiography. CLINICAL CHEMISTRY AND LABORATORY MEDICINE 450卷,10冊,237-242頁,104年  

研究計劃

  1. 許惠恒:新診斷糖尿病病人血中高糖化終產物與心臟血管疾病之角色(三年期計畫)(科技部計畫)
  2. 許惠恒:精胺酸轉化酶調控糖尿病腎臟纖維化之機轉探討(院內計畫)
  3. 許惠恒:探討芳香烴受體調控中間絲蛋白vimentin誘導之高血糖誘發腎絲球纖維化機轉(院內計畫)
  4. 許惠恒:芳香烴受體在高血糖誘發腎臟損傷之相關機轉探討(院內計畫)
  5. 許惠恒:醣類代謝終產物CML調控芳香烴受體在糖尿病腎病變纖維化機轉之探討(榮興計畫)
  6. 李奕德:類升糖激素胜太-1及二太基脢4抑制劑對芳香烴受體作用在糖尿病腎病變的影響(科技部計畫)
  7. 李奕德:腦源性神經滋養因子對血管细胞黏附分子的作用在動脈粥狀硬化之影響(院內計畫)
  8. 林時逸:探討交感神經系統與腫瘤壞死因子訊息傳遞路徑在肝硬化肌肉組織耗損過程泛素-蛋白酶體系統活化所扮演角色(院內計畫)
  9. 林時逸:芳香烴受體拮抗劑抑制高血糖誘發腎絲球纖維化機轉之探討(院內計畫)
  10. 林時逸:探討金錢薄荷膽汁鬱積肝損傷保護活性(榮靜計畫)
  11. 王俊興:肥胖的腎臟損傷---Adiponectin、AMPK與TLR4的角色(院內計畫)
  12. 王俊興:纖維母細胞生長因子19對內皮前驅細胞功能與血管傷害後內皮修復的影響(國衛院計畫)

103年 Sci

  1. A meta-analysis of genome-wide association studies for adiponectin levels in East Asians identifies a noel locus near WDR11-FGFR
  2. HUMAN MOLECULAR GENETICS,23卷,4冊,1108-19頁, 103年. 2. Improved prediction of cardiovascular events in diabetic patients: 
    Role of quantitative ultrasonic tissue characterization. Journal of Diabetes Investigation,5卷,4冊,17-18頁, 103年.有引述3篇論著
  3.  A young male adolescent with feminine appearance: diagnosis of 46, XX syndrome neglected for 4 years with gynaecomastia 
    presentation. ANDROLOGIA,46卷,3冊,325-8頁, 103年.
  4. Effects of Statins on Incident Dementia in Patients with Type 2 DM: A Population-Based Retrospective Cohort Study in Taiwan.
    PLoS One,9卷,2冊,e88434頁, 103年.
  5. Brain-derived neurotrophic factor, but not body weight, correlated with a reduction in depression scale scores in men with 
    metabolic syndrome: a prospective weight-reduction study. Diabetology & Metabolic Syndrome,6卷,18冊,1-7頁, 103年.
  6. The Chromosome 9p21 Variant Not Predicting Long-Term Cardiovascular Mortality in Chinese with Established Coronary Artery Disease: 
    An Eleven-Year Follow-Up Study.JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY,103卷,1冊,1-8頁, 103年.
  7. From sugar to kidney: A never-ending battle. Journal of Diabetes Investigation,1卷,1冊,1-2頁, 103年.未引述作者3篇論著
  8. Linkage analysis incorporating geneeage interactions identifies seven novel lipid loci: The Family Blood Pressure Program.
    ATHEROSCLEROSIS,235卷,1冊,84-93頁, 103年.
  9. Protective effects of rutin on liver injury induced by biliary obstruction in rats. FREE RADICAL BIOLOGY AND MEDICINE, 37卷, 1冊,
    106-116頁, 103年.
  10. Post-meal beta-cell function predicts the efficacy of glycemic control in patients with type 2 diabetes inadequately controlled by metformin 
    monotherapy after addition of glibenclamide or acarbose.Diabetology & Metabolic Syndrome, 103, 6:68  doi:10.1186/1758-5996-6-68
  11. Effect of prescription refill on quality of care among patients with type 2 diabetes: An exploratory study.DIABETES RESEARCH AND
    CLINICAL PRACTICE,105卷,1冊,110-118頁, 103年
  12. Meta-analysis of genome-wide association studies in East Asian-ancestry populations identifies four new loci for body mass index.
    HUMAN MOLECULAR GENETICS1卷,1冊,1-13頁, 103.
  13.  Acarbose Treatment and the Risk of Cardiovascular Disease in Type 2 Diabetic Patients: A Nationwide Seven-Year Follow-Up Study.
    Experimental Diabetes Research891(更名為Journal of Diabetes Research)1卷,1冊,1-6頁, 103年.
  14. Multiple Nonglycemic Genomic Loci Are Newly Associated With Blood Level of Glycated Hemoglobin in East Asians. DIABETES63卷,
    1冊,2551-2562頁, 103年.
  15. N-epsilon-carboxymethyllysine mediated ER stress promotes endothelial cell injury through Nox4/MKP-3 interaction. FREE RADICAL 
    BIOLOGY AND MEDICINE74卷,冊,294-306頁, 103年.
  16. Taurine protects HK-2 cells from oxidized LDL-induced cytotoxicity via the ROS-mediated mitochondrial and p53-related apoptotic 
    pathways. TOXICOLOGY AND APPLIED PHARMACOLOGY279卷,1冊,351-363, 103年.
  17. HGK/MAP4K4 deficiency induces TRAF2 stabilization and Th17 differentiation leading to insulin resistance. Nature Communications1卷,
    1冊,1-14, 103年.
  18. Activation of hepatic inflammatory pathways by catecholamines is associated with hepatic insulin resistance in male ischemic stroke rats.
    ENDOCRINOLOGY155卷,4冊,1235-1246, 103年
  19. Beneficial effect of quercetin on cholestatic liver injury. JOURNAL OF NUTRITIONAL BIOCHEMISTRY25卷,11冊,1183-1196頁,103年
  20. Systolic blood pressure as a predictor of incident albuminuria and rapid renal function decline in type 2 diabetic patients. JOURNAL OF 
    DIABETES AND ITS COMPLICATIONS28卷,1冊,779-784頁,103年
  21. Correlation between reduction of superior interventricular groove epicardial fat thickness and improvement of insulin resistance after 
    weight loss in obese men. Diabetology & Metabolic Syndrome6卷,115冊1-9頁,103年
  22. Insulinoma in a Young Female Patient with Systemic Lupus Erythematosus: A Case Report. Endocrine Practice20卷,12冊,e1-e4頁, 103年

 

Non-Sci

  1. Risk of rapid decline renal function in patients with type 2 diabetes.World Journal of diabetes5卷,6冊,835-846頁,103年

研究計劃

  1. 許惠恒:新診斷糖尿病病人血中高糖化終產物與心臟血管疾病之角色(三年期計畫)(科技部計畫)
  2. 許惠恒:高糖誘導內質網伴護蛋白Grp78降解引發巨噬細胞發炎反應之探討(院內計畫)
  3. 許惠恒:心血管疾病與運動行為及生活品質之相關性(院內計畫)
  4. 許惠恒:夜班輪值醫護人員之多面向評估及健康促進成效(院內計畫)
  5. 許惠恒:夜班輪值醫護人員之多面向評估(院內計畫)
  6. 許惠恒:探討芳香烴受體在高血糖引起腎絲球環間膜細胞發炎反應 (院內計畫)
  7. 許惠恒:芳香烴受體調控轉化生長因子-β1作用機轉之探討(院內計畫)
  8. 林時逸:探討骨骼肌胰島素訊號在壓力性高血糖的角色(院內計畫)
  9. 李奕德:類升糖激素胜太-1及二太基脢4抑制劑對芳香烴受體作用在糖尿病腎病變的影響(科技部計畫)
  10. 李奕德:二肽基酶-4抑制劑在腎臟對腦源性神經滋養因子的作用(院內計畫)
  11. 李奕德:肥胖的腎臟損傷---Adiponectin、AMPK與TLR4的角色(科技部計畫)
  12. 王俊興:T細胞MAP4K4與血糖異常及冠狀動脈疾病之關聯性(國衛院計畫)
  13. 王俊興:纖維母細胞生長因子對胰島素阻抗、增泌素荷爾蒙、血糖代謝異常、與缺血性中風的影響(科技部計畫)
  14. 王俊興:探討在肥胖的男性中,減重對單核球趨化蛋白對腎功能的影響(院內計畫)
  15. 傅家保:探討上皮-間質性轉型時共轉錄因子β-Catenin 調控之分子轉換在誘導幹細胞轉化所扮演的角色
  16. 李佳霖:探討CD133在癌幹細胞的形成及臨床運用上所扮演的角色(科技部計畫)
  17. 李佳霖:老化與語言處理網路結構的改變:老年人右腦語言功能的研究(科技部計畫)

102年 Sci

  1. Leptin to adiponectin ratio as a useful predictor for cardiac syndrome X. BIOMARKERS,18(1):44-50, 2013.
  2. Weight loss improves serum mediators and metabolic syndrome features in android obese subjects. Obesity Research & Clinical Practice,2013(7):e81-e88, 2013. :18-1
  3. Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study. LANCET,381(1):117-124, 2013 :381-6
  4. Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study JOURNAL OF INTERNAL MEDICINE,273(1):102-110, 2013.
  5. Safety and efficacy of twice-daily exenatide in Taiwanese patients with inadequately controlled type 2 diabetes mellitus. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION,112卷,1冊,144-150頁, 2013年.
  6. Effects of weight loss on epicardial adipose tissue thickness and its relationship between serum soluble CD40 ligand levels in obese men .CLINICA CHIMICA ACTA,421卷,1冊,98-103頁, 2013年
  7. Performance of HbA1c and Fasting Plasma Glucose in Screening for Diabetes in Patients Undergoing Coronary Angiography. DIABETES CARE,36卷,5冊,1138-1140頁, 2013年(5月)
  8. Trans-Ethnic Fine-Mapping of Lipid Loci Identifies Population-Specific Signals and Allelic Heterogeneity That Increases the Trait Variance Explained. PLoS Genetics,9卷,3冊,1-16頁, 2013年.
  9. Trends of ABC control 2006–2011: A National Survey of Diabetes Health Promotion Institutes in Taiwan. DIABETES RESEARCH AND CLINICAL PRACTICE,99卷,1冊,112-119頁, 2013年
  10.  Advanced glycation end product Nε-carboxymethyllysine induces endothelial cell injury: the involvement of SHP-1-regulated VEGFR-2 dephosphorylation. Journal of Pathology 2013; 230: 215–227.
  11. Hyperglycemia Accelerates ATP-Binding Cassette Transporter A1 Degradation Via an ERK-Dependent Pathway in Macrophages. JOURNAL OF CELLULAR BIOCHEMISTRY,114卷,1冊,1364-73頁, 2013年.
  12. High triglyceride-to-HDL cholesterol ratio associated with albuminuria in type 2 diabetic subjects. JOURNAL OF DIABETES AND ITS COMPLICATIONS,27卷,3冊,243-7頁, 2013年.
  13. Leptin to adiponectin ratio as a useful predictor for cardiac syndrome X. BIOMARKERS,18(1):44-50, 2013.
  14. Weight loss improves serum mediators and metabolic syndrome features in android obese subjects. Obesity Research & Clinical Practice,2013(7):e81-e88, 2013. 
  15. Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study.LANCET,381(1):117-124, 2013.
  16. Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study. JOURNAL OF INTERNAL MEDICINE,273(1):102-110, 2013.
  17. Safety and efficacy of twice-daily exenatide in Taiwanese patients with inadequately controlled type 2 diabetes mellitus.JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION,112卷,1冊,144-150頁, 2013年.
  18. Effects of weight loss on epicardial adipose tissue thickness and its relationship between serum soluble CD40 ligand levels in obese men. CLINICA CHIMICA ACTA,421卷,1冊,98-103頁, 2013年
  19. Performance of HbA1c and Fasting Plasma Glucose in Screening for Diabetes in Patients Undergoing Coronary Angiography.DIABETES CARE,36卷,5冊,1138-1140頁, 2013年(5月)
  20. Trans-Ethnic Fine-Mapping of Lipid Loci Identifies Population-Specific Signals and Allelic Heterogeneity That Increases the Trait Variance Explained. PLoS Genetics,9卷,3冊,1-16頁, 2013年.
  21. Trends of ABC control 2006–2011: A National Survey of Diabetes Health Promotion Institutes in Taiwan. DIABETES RESEARCH AND CLINICAL PRACTICE,99卷,1冊,112-119頁, 2013年
  22.  Advanced glycation end product Nε-carboxymethyllysine induces endothelial cell injury: the involvement of SHP-1-regulated VEGFR-2 dephosphorylation. Journal of Pathology 2013; 230: 215–227.
  23. Hyperglycemia Accelerates ATP-Binding Cassette Transporter A1 Degradation Via an ERK-Dependent Pathway in Macrophages. JOURNAL OF CELLULAR BIOCHEMISTRY,114卷,1冊,1364-73頁, 2013年.
  24. High triglyceride-to-HDL cholesterol ratio associated with albuminuria in type 2 diabetic subjects. JOURNAL OF DIABETES AND ITS COMPLICATIONS,27卷,3冊,243-7頁, 2013年

Non-Sci

  1. *新陳代謝科:許副恆(副院長)低血糖與認知功能障礙:當代醫學,40卷,1冊,7-9頁, 2013年.研究計劃
  2. 許惠恆:探討在肥胖中miR-33調控脂肪酸代謝及膽固醇運送之機制(TCVGH-1020101C)(院內計劃)
  3. 許惠恆:過氧化酶體增生活化受器調控血基質氧化酶作用機轉之探討(院內計劃)
  4. 許惠恆:糖尿病大血管病變病理狀態中過氧化物與內質網壓力暨發炎因子訊息傳遞 (院內計劃)
  5. 林時逸:糖尿病小鼠高血糖誘導內質網中凋亡蛋白GADD153 表現之探討(TCVGH-1023506D)(院內計劃)
  6. 林時逸:探討脂肪組織炎症反應特性(TCVGH-1023503C)(院內計劃)
  7. 傅家保:在肥胖的男性中,探討減重在血清中可溶性CD40L和心外膜脂肪組織關聯性的影響(TCVGH-1023501A)(院內計劃)
  8. 張心玫:肝臟腫瘤病人甲狀腺功能與肝臟腫瘤之去碘酶表現之相關性研究探討(TCVGH-1023502A)(院內計劃)
  9. 李奕德:腦源性神經滋養因子對糖尿病腎病變的影響(TCVGH-1023504C)(院內計劃)
  10. 王俊興:Toll-like receptor 4 在高脂飲食誘發腎臟疾病的角色(TCVGH-1023505C)(院內計劃)

101年 Sci

  1. Mu YM, Misra A, Adam JM, Chan SP, Chow FC, Cunanan EC, Deerochanawong C, Jang HC, Khue NT, Sheu WH, Tan KE. Managing diabetes in Asia: Overcoming obstacles and the role of DPP-IV inhibitors. Diabetes Res Clin Pract. 2012 Feb;95(2):179-88.
  2. Sheen YJ, Lin JL, Lee IT, Hsu YN, Li TC, Sheu WH. Low estimated glomerular filtration rate is a major determinant of low ankle-brachial index and toe-brachial index in type 2 diabetes. Angiology. 2012 Jan;63(1):55-61.
  3. Chang YC, Chiu YF, Liu PH, Shih KC, Lin MW, Sheu WH, Quertermous T, Curb JD, Hsiung CA, Lee WJ, Lee PC, Chen YT, Chuang LM. Replication of genome-wide association signals of type 2 diabetes in Han Chinese in a prospective cohort. Clin Endocrinol (Oxf). 2012 Mar;76(3):365-72.
  4. Lee IT, Lee WJ, Tsai CM, Su IJ, Yen HT, Sheu WH. Combined extractives of red yeast rice, bitter gourd, chlorella, soy protein, and licorice improve total cholesterol, low-density lipoprotein cholesterol, and triglyceride in subjects with metabolic syndrome. Nutr Res. 2012 Feb;32(2):85-92.
  5. Lee IT, Lee WJ, Tsai IC, Liang KW, Lin SY, Wan CJ, Fu CP, Sheu WH. Brain-derived neurotrophic factor not associated with metabolic syndrome but inversely correlated with vascular cell adhesion molecule-1 in men without diabetes. Clin Chim Acta. 2012 May 18;413(9-10):944-8.
  6. Mechanick JI, Marchetti AE, Apovian C, Benchimol AK, Bisschop PH, Bolio-Galvis A, Hegazi RA, Jenkins D, Mendoza E, Sanz ML, Sheu WH, Tatti P, Tsang MW, Hamdy O. Diabetes-specific nutrition algorithm: a transcultural program to optimize diabetes and prediabetes care. Curr Diab Rep. 2012 Apr;12(2):180-94.
  7. Su HY, Tsang MW, Huang SY, Mechanick JI, Sheu WH, Marchetti A; Task Force for Development of Transcultural Algorithms in Nutrition and Diabetes. Transculturalization of a diabetes-specific nutrition algorithm: Asian application. Curr Diab Rep. 2012 Apr;12(2):213-9.
  8. Liang KW, Tsai IC, Lee WJ, Lee IT, Lee WL, Lin SY, Wan CJ, Fu CP, Ting CT, Sheu WH. MRI measured epicardial adipose tissue thickness at the right AV groove differentiates inflammatory status in obese men with metabolic syndrome. Obesity (Silver Spring). 2012 Mar;20(3):525-32.
  9. Ou HC, Lee WJ, Wu CM, Chen JF, Sheu WH. Aspirin prevents resistin-induced endothelial dysfunction by modulating AMPK, ROS, and Akt/eNOS signaling. J Vasc Surg. 2012 Apr;55(4):1104-15.  
  10. Wang TM, Chen CJ, Lee TS, Chao HY, Wu WH, Hsieh SC, Sheu HH, Chiang AN. Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells. J Nutr Biochem. 2011 Feb;22(2):187-94.  
  11. Sheu WH, Ji LN, Nitiyanant W, Baik SH, Yin D, Mavros P, Chan SP. Hypoglycemia is associated with increased worry and lower quality of life among patients with type 2 diabetes treated with oral antihyperglycemic agents in the Asia-Pacific region. Diabetes Res Clin Pract. 2012 May;96(2):141-8.  
  12. Sheu WH. Addressing self-monitoring of blood glucose: Advocating paired glycemic testing for people with type 2 diabetes. Journal of Diabetes Investigation.2012;3(4):337-8.  
  13. Sheen YJ, Sheu WH. Links among type 2 diabetes, cancer and metformin use: What have we learned? Diabetes Res Clin Pract. 2012 Aug;97(2):169-71.  
  14. Lee IT, Chiu YF, Hwu CM, He CT, Chiang FT, Lin YC, Assimes T, Curb JD, Sheu WH. Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study. Cardiovasc Diabetol. 2012 Apr 26;11:43.  
  15. Fu CP, Lee IT, Sheu WH, Lee WJ, Liang KW, Lee WL, Lin SY. The levels of circulating and urinary monocyte chemoattractant protein-1 are associated with chronic renal injury in obese men. Clin Chim Acta. 2012 Oct 9;413(19-20):1647-51.  
  16. Chen WY, Lin SY, Pan HC, Liao SL, Chuang YH, Yen YJ, Lin SY, Chen CJ. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats. J Nutr Biochem. 2012 Mar;23(3):252-64.
  17. Chang CY, LEE TH, Sheu WH. Anti-atherogenic effects of resveratrol via liver x receptor α-dependent upregulation of ATP-binding cassette transporters A1 and G1 in  macrophages. Journal of Functional Foods 2012;4:727-735.
  18. Lee IT, Hung YJ, Chen JF, Wang CY, Lee WJ, Sheu WH. Comparison of the Efficacy and Safety Profiles of Two Fixed-Dose Combinations of Antihypertensive Agents, Amlodipine/Benazepril Versus Valsartan/Hydrochlorothiazide, in Patients With Type 2 Diabetes Mellitus and Hypertension: A 16-Week, Multicenter, Randomized , Double-Blind, Noninferiority Study. Clin Ther. 2012 Aug;34(8):1735-50.
  19. Wang CY, Lin CL, Huang TS, Chien MN, Hsieh SH, Huang YY, Shih KC, Tu ST, Chang CT, Chien-Ning H, Chou CW, Wu TJ, Liu RT, Lam HC, Kwok CF, Fu CC, Sheu WH. Inertia on hypoglycemia: highlight from a Taiwan subgroup analysis of Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) study. Diabetes Res Clin Pract. 2012 Oct;98(1):61-7.
  20. Hsiao CF, Sheu WW, Hung YJ, Lin MW, Curb D, Ranadex K, Quertermous T, Chen YM, Chen IY, Wu KD. The effects of the renin-angiotensin-aldosterone system gene polymorphisms on insulin resistance in hypertensive families. J Renin Angiotensin Aldosterone Syst. 2012 Dec;13(4):446-54.
  21. Tseng LN, Tseng YH, Jiang YD, Chang CH, Chung CH, Lin BJ, Chuang LM, Tai TY, Sheu WH. Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: An analysis of nationwide data for 2000-2009. J Formos Med Assoc. 2012 Nov;111(11):625-36.

Non-Sci

  1. *新陳代謝科:許承嵐、*許惠恒(副院長)血管張力素受體阻斷劑(ARB)早期預防糖尿病腎病變:ROADMAP研究之啟示.當代醫學. 2012;39(7):496-9.
  2. 新陳代謝科:李佳霖、許惠恒(副院長)A two-year follow up of glycated hemoglobin in a group of oralantidiabetic or insulin users in a medical center in central Taiwan.Formosan 
    Journal of Endocrinology and Metabolism. 2012;3(1):1-6.
  3. 感染科、*新陳代謝科:林芸合、*許惠恒(副院長)Urinary Tract Infection in Diabetes Mellitus: An Update.Journal of Internal Medicine of Taiwan.
    2012;23(3):173-182.
  4. 新陳代謝科:許承儒、許惠恒(副院長)第二型糖尿病病患血壓控制之理想目標.當代醫學. 2012;39(10):785-787.

研究計劃

  1. 許惠恆:新診斷糖尿病病人血中高糖化終產物與心臟血管疾病之角色(三年期計畫)(NSC 101-2314-B-075A-006-MY3)(國科會計畫)
  2. 許惠恆:高血壓暨胰島素抗性遺傳基因研究以及後續心血管疾病發生之追蹤研究計畫 (PH-101-PP-03)(國家衛生研究院計畫)  
  3. 許惠恆:MicroRNA-33在糖尿病合併血脂異常及心臟血管疾病的角色研究(II    )(TCVGH-YM1010102 )(榮陽計畫)  
  4. 許惠恆:去磷酸酶MKP3在糖尿病腎病變角色之探討(TCVGH-NCHU1017603)(榮興計畫)  
  5. 許惠恆:高血糖誘導內質網壓力調控Grp78裂解機轉之探討(TCVGH-HK1018001)(榮弘計畫)
  6. 許惠恆:在糖尿病腎病變病理狀態中發炎物質與訊息傳遞機轉之探討(院內計畫)
  7. 許惠恆:白藜蘆醇對吞噬細胞反向膽固醇轉送及細胞凋零之影響: mTOR角色探討 (TCVGH-1013001C)(院內計畫)
  8. 林時逸:探討壓力性高血糖的生物意義及變化機制99-2314-B-075A-003-MY3 (新制多年期)(國科會計畫)
  9. 林時逸:兒童期與青少年期與成年期使用高脂肪誘發肥胖小鼠對於成年時糖份代謝與脂肪組織發炎細胞激素改變之探討(院內計畫)
  10. 林時逸:高血糖狀態誘導腎絲球環間膜細胞導致HMGB1蛋白生成機轉之探討(院內計畫)
  11. 李奕德:腦源性神經滋養因子與動脈硬化關係之研究(院內計畫)
  12. 王俊興:內皮前驅細胞在接受心導管檢查患者合併口服葡萄糖耐量試驗診斷血糖異常之研究(院內計畫)

100年 Sci

  1. Wang TMChen CJLee TSChao HYWu WHHsieh SCSheu HHChiang AN.Docosahexaenoic acid attenuates VCAM-1 expression and NF-κB activation in TNF-α-treated human aortic endothelial cells.J Nutr Biochem. 2011 Feb;22(2):187-94.
  2. Chiang SCLee JKChen CHChuang LMTsan KWSheu WHWu DAWu TJLin KCJuang JHWang CYHo LT. Justifying the high prevalence of microalbuminuria for type 2 diabetic patients in Taiwan with conditional probability approach- a DEMAND II study. J Chin Med Assoc. 2011 Jan;74(1):3-10.
  3. Kuo MY, Ou HC, Lee WJ, Kuo WW, Hwang LL, Song TY, Huang CY, Chiu TH, Tsai KL, Tsai CS, Sheu WHEllagic acid inhibits oxidized low-density lipoprotein (OxLDL)-induced metalloproteinase (MMP) expression by modulating the protein kinase C-α/extracellular signal-regulated kinase/peroxisome proliferator-activated receptor γ/nuclear factor-κB (PKC-α/ERK/PPAR-γ/NF-κB) signaling pathway in endothelial cells. J Agric Food Chem. 2011 May 11;59(9):5100-8.
  4. Wang JSTu STLee ITLin SDLin SYSu SLLee WJSheu WH. Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring.Diabetes Metab Res Rev. 2011 Jan;27(1):79-84.
  5. Sheu WHRosman AMithal AChung NLim YTDeerochanawong CSoewondo PLee MKYoon KHSchnell O. Addressing the burden of type 2 diabetes and cardiovascular disease through the management of postprandial hyperglycaemia: An Asian-Pacific perspective and expert recommendations. Diabetes Res Clin Pract. 2011 Jun;92(3):312-21.
  6. Sheu WHChuang HCCheng SMLee MRChou CCCheng FC. Microdialysis combined blood sampling technique for the determination of rosiglitazone and glucose in brain and blood of gerbils subjected to cerebral ischemia. J Pharm Biomed Anal. 2011 Mar 25;54(4):759-64.
  7. Lang HF, Chou CY, Sheu WHLin JYWeight loss increased serum adiponectin but decreased lipid levels in obese subjects whose body mass index was lower than 30 kg/m(2). Nutr Res. 2011 May;31(5):378-86.
  8. Liang KW, Lee WJ, Lee IT, Lee WL, Lin SY, Hsu SL, Wan CJ, Yu CY, Tsai IC, Fu CP, Ting CT, Sheu WH. Persistent elevation of paraoxonase-1 specific enzyme activity after weight reduction in obese non-diabetic men with metabolic syndrome. Clin Chim Acta. 2011 Sep 18;412(19-20):1835-41. Epub 2011 Jun 17.
  9. Hwang JH, Lee IT, Jeng KC, Wang MF, Hou RCW, Wu SM, Chan YC. Spirulina prevents memory dysfunction, reduces oxidative stress damage and augments antioxidant activity in senescence-accelerated mice. Journal of Nutritional Science and Vitaminology  2011;57(2):186-191.
  10. Lin SD, Wang JS, Hsu SR, Sheu WH, Tu ST, Lee IT, Su SL, Lin SY, Wang SY, Hsieh MC. The beneficial effect of α-glucosidase inhibitor on glucose variability compared with sulfonylurea in Taiwanese type 2 diabetic patients inadequately controlled with metformin: preliminary data. J Diabetes Complications. 2011 Sep-Oct;25(5):332-8.
  11. Chan JC, Chan SP, Deerochanawong C, Go RT, Lee KO, Ma RC, Pan CY, Sheu WH, Barter P. Diabetic dyslipidaemia in Asian populations in the Western Pacific Region: What we know and don't know. Diabetes Res Clin Pract. 2011 Oct;94(1):1-13.
  12. Wang JS, Lin SD, Lee WJ, Su SL, Lee IT, Tu ST, Tseng YH, Lin SY, Sheu WH. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison. Clin Ther. 2011 Dec;33(12):1932-42.

Non-Sci

  1. 新陳代謝科:許惠恒(部主任). Alteration of insulin sensitivity by sex hormones during the menstrual cycle Journal of Diabetes Investigation. 2011;52(2):258-259.
  2. *新陳代謝科:沈宜靜(院外人士)、*許惠恒(部主任). Metabolic syndrome and renal injury.Cardiology research and practice. 2011;1-13.
  3. *新陳代謝科:沈宜靜(院外人士)、林建良(院外人士)、*許惠恒(部主任). 糖尿病與癌症之關聯以及台灣現況探討. 內科學誌. 2011;22(1):19-30.
  4. 新陳代謝科:陳拓邦(住院醫師)、林時逸(科主任)、許惠恒(部主任). Statin’s Effect on New Incident Diabetes and Blood Glucose Control.史塔丁對新生糖尿病與血糖控制之影響. Journal of Internal Medicine of Taiwan 2011;22(2):106-114.
  5. *新陳代謝科:許承儒(院外人士)、*許惠恒(部主任). 餐後血糖控制在糖尿病之重要性. 當代醫學. 2011;38(11):858-860.
  6. *新陳代謝科:許承嵐(院外人士)、*許惠恒(部主任). 減重手術緩解第二型糖尿病. 當代醫學. 2011;38(10):744-747.
  7. 新陳代謝科:傅家保(住院醫師)、林時逸(科主任)、王俊興、許惠恒(部主任). Primary hypoparathyroidism with an initial presentation of carpal tunnel syndrome: a case report. Formosa J Endocrin Metab. 2011;2:44-48.
  8. 復建科、*新陳代謝:沈惠民(住院醫師)、林東亮、鍾進燈、*許惠恒(部主任). 糖尿病足之臨床評估與治療. 內科學誌. 2011;22(4):254-265.

研究計劃

  1. 許惠恒:體重變化時脂肪組織中吞噬細胞之功能特性與胰島素阻抗之關連NSC98-2314-B-075A-002-MY3總執行期限:98/08/01-101/07/31(國科會新制多年期
  2. 許惠恒:高血壓暨胰島素抗性遺傳基因研究以及後續心血管疾病發生之追蹤研究計畫  PH-099-PP-03(國衛院)
  3. 許惠恒:MicroRNA-33在糖尿病合併血脂異常及心臟血管疾病的角色研究(TCVGH-YM1000102)(中榮、陽明任務導向型計畫
  4. 許惠恒:白藜蘆醇對吞噬細胞內反向膽固醇轉送機轉之研究 (TCVGH-1003001C)(院內計劃)
  5. 許惠恒:MAP4K4在氧化低密度脂蛋白刺激內皮細胞發炎之角色研究 (中榮、國衛院)
  6. 許惠恒:探討PPAR gamma促進劑調節高度糖基化產物羧甲基離氨基酸誘導人類血管內皮細胞功能缺失之機轉 (TCVGH-HK1008001)(榮弘)
  7. 林時逸:探討壓力性高血糖的生物意義及變化機制 (1/3) 99/08/01-102/07/31 (國科會三年期計畫)
  8. 林時逸:探討芸香素膽汁鬱積肝損傷保護活性 (院內計劃)
  9. 傅家保:在無併發症的肥胖男性中,評估血清中單核球趨化蛋白濃度與Cystatin C的關聯性 (院內計劃)

99年 Sci

  1. Lee ITLiau YJLee WJHuang CNSheu WHContinuous subcutaneous insulin infusion providing better glycemic control and quality of life in Type 2 diabetic subjects hospitalized for marked hyperglycemia. Eval Clin Pract. 2010 Feb;16(1):202-5.
  2. Lin SY, Huang SC, Sheu WH. Circulating adiponectin concentrations were related to free thyroxine levels in thyroid cancer patients after thyroid hormone withdrawal. Metabolism. 2010 Feb;59(2):195-9. Epub 2009 Sep 17.
  3. Wang YYLin SYSheu WHLiu PHTung KCObesity and diabetic hyperglycemia were associated with serum alanine aminotransferase activity in patients with hepatitis B infection. Metabolism. 2010 Apr;59(4):486-91. Epub 2009 Oct 20.
  4. Wang YYLin SYChuang YHMao CHTung KCSheu WHProtein nitration is associated with increased proteolysis in skeletal muscle of bile duct ligation-induced cirrhotic rats. Metabolism. 2010 Apr;59(4):468-72. Epub 2009 Oct 20.
  5. Lin YY, Hsu CW, Sheu WH, Chu SJ, Wu CP, Tsai SH. Risk factors for recurrent hypoglycemia in hospitalized diabetic patients admitted for severe hypoglycemia. Yonsei Med J. 2010 May;51(3):367-74.
  6. 張以承、莊立民、邵逸民、許惠恒、郭清輝、何橈通. Epidemiology Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999-2004: a national health insurance data set study. Diabetic Medicine.  2010, 27, 636-643.
  7. Gkrania-Klotsas E, Ye Z, Cooper AJ, Sharp SJ, Luben R, Biggs ML, Chen LK, Gokulakrishnan K, Hanefeld M, Ingelsson E, Lai WA, Lin SY, Lind L, Lohsoonthorn V, Mohan V, Muscari A, Nilsson G, Ohrvik J, Chao Qiang J, Jenny NS, Tamakoshi K, Temelkova-Kurktschiev T, Wang YY, Yajnik CS, Zoli M, Khaw KT, Forouhi NG, Wareham NJ, Langenberg C. Differential White Blood Cell Count and Type 2 Diabetes: Systematic Review and Meta-Analysis of Cross-Sectional and Prospective Studies. PLoS One. 2010 Oct 18;5(10):e13405.

Non-Sci

  1. 張寶文,宋育民,林時逸,許惠恒. A case of aldosterone-Producing adrenocortical adenoma complicated with a post-operative adrenal glucocorticoid insufficiency. Formosan Journal of Endocrinology and Metabolism 2010;2:12-16.
  2. 賴韻如,許惠恒,林時逸,廖翊儒,劉秀珍,李奕德. Preliminary clinical application of standard ward-based procedures for preventing hospital hypoglycemia in the general internal medicine ward. Formosan Journal of Endocrinology and Metabolism 2010;2:5-11.
  3. 盧英立,林時逸,許惠恒. Reversible dilated cardiomyopathy in thyrotoxicosis- A case report. Formosan Journal of Endocrinology and Metabolism 2010;2:26-30.

研究計劃

  1. 許惠恒:體重變化時脂肪組織中吞噬細胞之功能特性與胰島素阻抗之關連NSC98-2314-B-075A-002-MY3總執行期限:98/08/01-101/07/31(國科會新制多年期)
  2. 許惠恒:高血壓暨胰島素抗性遺傳基因研究以及後續心血管疾病發生之追蹤研究計畫  PH-099-PP-03 (國衛院)
  3. 許惠恒:肥胖鼠體重改變時脂肪細胞與巨噬細胞之交互作用 (院內計劃)
  4. 許惠恒:探討去磷酸脢MKP3調控血管內皮細胞功能缺失之機轉 (榮興計劃)
  5. 林時逸:腫瘤壞死因子與肝硬化骨骼肌肉細胞凋亡之相關性探討.96/08/01-99/07/31 (國科會三年期計畫)
  6. 林時逸:探討壓力性高血糖的生物意義及變化機制 (1/3) 99/08/01-102/07/31 (國科會三年期計畫)
  7. 林時逸:腦部缺血性中風老鼠是否合併肝臟胰島抗性之探討 (院內計劃)
  8. 林時逸:脂肪酸與巨噬細胞對胰臟B細胞發炎反應之相互影響探討 (榮台聯大)

98年 Sci

  1. Huang, S. C., V. C. Wu, et al. Factors Related to Clinical Hypothyroid Severity in Thyroid Cancer Patients after Thyroid Hormone Withdrawal. Thyroid 19(1): 13-20, 2009.
  2. Lai, Y. J., S. Y. Lin, et al. Graves Disease After Thyroid Hormone Treatment for Thyroid Nodule. Endocrinologist 19(2): 73-74, 2009.
  3. Lee, I. T., W. J. Lee, et al. (2009). "Metabolic syndrome abating the beneficial effect of pravastatin treatment on adhesion of endothelium by monocytes in subjects with hypercholesterolemia." Metabolism-Clinical and Experimental 58(3): 416-420.
  4. Lee, I. T., H. C. Liu, et al. Improvement in health-related quality of life, independent of fasting glucose concentration, via insulin pen device in diabetic patients. Journal of Evaluation in Clinical Practice 15(4): 699-703, 2009.
  5. Lee, W. J., C. S. Wu, et al. Visfatin-induced expression of inflammatory mediators in human endothelial cells through the NF-kappa B pathway. International Journal of Obesity 33(4): 465-472, 2009.
  6. Liang, K. W., W. J. Lee, et al.Decreased ratio of high-molecular-weight to total adiponectin is associated with angiographic coronary atherosclerosis severity but not restenosis. Clinica Chimica Acta 405(1-2): 114-118, 2009.
  7. Lin, Y. Y., C. W. Hsu, et al. Use of therapeutic responses to glucose replacement to predict glucose patterns in diabetic patients presenting with severe hypoglycaemia. International Journal of Clinical Practice 63(8): 1161-1166, 2009.
  8. Ou, H. C., W. J. Lee, et al. Ginkgo biloba extract attenuates oxLDL-induced oxidative functional damages in endothelial cells. Journal of Applied Physiology 106(5): 1674-1685, 2009.
  9. Sheu, W. H. H., C. M. Wu, et al. Effect of Weight Loss on Proinflammatory State of Mononuclear Cells in Obese Women Response. Obesity 17(5): 934-935, 2009.
  10. Song, Y. M. and M. D. Chen. Effects of melatonin administration on plasma leptin concentration and adipose tissue leptin secretion in mice. Acta Biologica Hungarica 60(4): 399-407, 2009.
  11. Sung, S. H., S. Y. Chuang, et al. Relation of Adiponectin and High-Sensitivity C-Reactive Protein to Pulse-Wave Velocity and N-Terminal Pro-B-Type Natriuretic Peptide in the General Population.  American Journal of Cardiology 103(10): 1411-1416, 2009.
  12. Yu, N. C., H. Y. Su, et al. ABC control of diabetes: Survey data from National Diabetes Health Promotion Centers in Taiwan. Diabetes Research and Clinical Practice 84(2): 194-200, 2009
  13. Wang, J. S., Lin, S. Y., Sheu, W. H. H., Li, Y. T., Tseng, L. N., Song, Y. M. Effects of patient volume on quality of outpatient diabetes care. Diabetes Res Clin Pract. May;84(2): e27-9, 2009.

Non-Sci

  1. 陳盈佑. Pheochromocytoma presenting with normal urinary catecholamines and metabolities: A case report. Formosan Journal of Endocrinology and Metabolism 2009;1:33-37.

研究計劃

  1. 許惠恒: 探討脂肪組織如何影響巨噬細胞中的resistin和visfatin等的調控機制. 98/01/01-98/12/31. 院內計畫.
  2. 許惠恒: 使用高脂肪餵食誘發肥胖小鼠探討肥胖對組織造成之病理傷害、機轉與可能治療方式. 98/01/01-98/12/31. 榮台計畫.
  3. 許惠恒: 高度糖基化產物梭甲基離氨基酸誘導人類血管內皮細胞凋亡之機轉. 98/01/01-98/12/31.榮興計畫.
  4. 許惠恒: 體重變化時脂肪組織中吞噬細胞之功能特性與胰島素阻抗之關連 (三年期計畫). 98/08/01-101/07/31. 國科會計畫.
  5. 許惠恒: 胰島素増敏藥物對脂肪細胞素引起內皮細胞功能失調之影響 (三年期計畫). 95/08/01-98/07/31. 國科會計畫.
  6. 許惠恒: 高血壓暨胰島素抗性遺傳基因研究以及後續心血管疾病發生之追蹤研究計畫. 98/01/01-98/12/31. 衛生署計畫.
  7. 許惠恒: 以健康食品改善代謝症候群之臨床研究 (二年期計畫). 96/08/01-98/07/31. 衛生署計畫.
  8. 林時逸: 脂肪酸抗肝纖維化活性分析. 98/01/01-98/12/31. 院內計畫.
  9. 林時逸: 內毒素在高脂飲食誘發肥胖鼠之胰臟胰島發炎機轉之探討. 980101-981231. 榮台聯大計畫.
  10. 林時逸: 肝硬化骨骼肌肉細胞凋亡研究 (三年期計畫). 96/08/01-99/07/31. 國科會計畫.
  11. 曾立年: 減重對骨代謝指標及血脂肪細胞素與發炎指標的影響. 98/01/01-98/12/31. 院內計畫.
  12. 李奕德: 蔓越莓對糖尿病患者神經的影響. 98/01/01-98/12/31. 院內計畫.
  13. 李奕德: 藍綠藻緩解老化機制之探討. 98/01/01-98/12/31. 榮靜計畫.

 


回頂端